TCR Therapy Market Report 2026

TCR Therapy Market Overview

• TCR Therapy market size has reached to $0.26 billion in 2025 • Expected to grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 34.8% • Growth Driver: The Increasing Incidence Of Cancer Fueling The Growth Of The Market Due To Rising Global Disease Burden And Demand For Targeted Immunotherapies • Market Trend: Strategic Partnerships Driving Innovation In The TCR Therapy Industry • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under TCR Therapy Market?

T-cell receptor (TCR) therapy refers to a form of immunotherapy that involves modifying a patient's T cells to better recognize and attack cancer cells. It is primarily used as a treatment for cancer and is designed to harness the power of the body's own immune system to target and destroy cancer cells. The main types of TCR therapy are infusions, injectables, and others. Infusions generally refer to the process of steeping or soaking a substance (such as herbs, tea leaves, or flavorings) in a liquid (usually hot water) to extract its flavor or properties. It is used to treat various indications, such as leukemia, lymphoma, myeloma, and others, and it is distributed through online and offline channels. It is used by several end-users, including hospital pharmacies, retail pharmacies, and specialty clinics.

What Is The TCR Therapy Market Growth Forecast?

The tcr therapy market size is expected to see exponential growth in the next few years. It will grow to $1.15 billion in 2030 at a compound annual growth rate (CAGR) of 34.8%. The growth in the forecast period can be attributed to growth in off-the-shelf allogeneic tcr therapies, integration of ai for tcr design, expansion in emerging markets, regulatory approvals for new tcr indications, advancements in combination immunotherapy approaches. Major trends in the forecast period include personalized tcr therapy development, off-the-shelf allogeneic tcr therapies, combination immunotherapy approaches, expansion of hospital and specialty clinic access, advanced tcr gene editing techniques.

Global TCR Therapy Market Segmentation

1) By Product Type: Infusions, Injectables, Other Product Types 2) By Indication: Leukemia, Lymphoma, Myeloma, Other Indication 3) By Distribution Channel: Online, Offline 4) By End-User: Hospital Pharmacy, Specialty Clinics Subsegments: 1) By Infusions: Autologous TCR Infusions, Allogeneic TCR Infusions 2) By Injectables: TCR-based Injectable Formulations, Injectable TCR Gene Therapies 3) By Other Product Types: TCR-Engineered Cell Therapies, TCR Combination Therapies with Other Immunotherapies, TCR-Based Biologics

What Is The Driver Of The TCR Therapy Market?

The increasing incidence of cancer is expected to propel the growth of the T-cell receptor (TCR) therapy market going forward. Cancer is a group of diseases marked by the uncontrolled growth and spread of abnormal cells, driven by factors such as aging populations, lifestyle-related risks, genetic predispositions, and environmental exposures. The rise in cancer cases is expanding the global disease burden, creating an urgent need for advanced therapeutic approaches that offer more precise and durable clinical outcomes. TCR therapy supports this growing medical demand by engineering T cells to specifically recognize and destroy cancer cells, providing a highly targeted immunotherapy option for complex and treatment-resistant tumors. For instance, according to the American Cancer Society, a US-based non-profit organization, the estimated number of new lymphoma cancer cases increased from 89,010 in 2022 to 89,380 in 2023. Therefore, the increasing incidence of cancer is driving the growth of the TCR therapy industry.

Key Players In The Global TCR Therapy Market

Major companies operating in the tcr therapy market are Immunocore Limited, Immatics N.V., Adaptimmune Therapeutics plc, Alaunos Therapeutics Inc., Zelluna Immunotherapy AS, Lion TCR Pte Ltd, TCRCure Biopharma Corp., China Immunotech Inc., Bluebird bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Atara Biotherapeutics Inc., Precision Biosciences Inc., Cellectis S.A., Cellular Biomedicine Group Inc., Takara Bio Inc., Tessa Therapeutics, Pfizer Inc., Novartis AG, Bristol Myers Squibb Company

Global TCR Therapy Market Trends and Insights

Major companies operating in the TCR therapy industry are adopting a strategic partnership approach to provide essential treatments to patients and gain a competitive edge in the market. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in December 2023, ImmunoScape, a US-based biotechnology company, partnered with the Experimental Drug Development Centre (EDDC), a Singapore-based pharmaceutical company, to develop new TCR-based bispecific molecules for solid tumors. This partnership aims to leverage ImmunoScape's expertise in systems immunology and computational biology, along with EDDC's capabilities, to advance research in this field and create a strategic alliance that leverages their unique strengths to accelerate the development of more accessible and potentially more effective cancer treatments.

What Are Latest Mergers And Acquisitions In The TCR Therapy Market?

In January 2023, AstraZeneca, a UK-based pharmaceutical and biotechnology company acquired Neogene Therapeutics Inc. for $320 million. This acquisition allowed AstraZeneca to significantly enhance its position in the burgeoning field of TCR-T therapy. AstraZeneca gained access to cutting-edge technology, valuable expertise, and a shared passion for developing new cancer treatments, ultimately aiming to improve the lives of patients with various cancer types. Neogene Therapeutics Inc. is a US-based operator of a biotechnology company intended to develop next-generation, fully personalized engineered T-cell therapies for a broad spectrum of cancers.

Regional Insights

North America was the largest region in the TCR therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the TCR Therapy Market?

The TCR therapy market consists of revenues earned by entities by providing services such as genetic engineering services, quality control and assurance, clinical trial support, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The TCR therapy market also includes sales of TCR constructs, genetic modification tools, viral vectors, delivery systems, cell culture media and reagents, patient monitoring tools, and bioinformatics and data analysis tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the TCR Therapy Market Report 2026?

The tcr therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the tcr therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.